Curocell Inc. (KOSDAQ:372320)
South Korea · Delayed Price · Currency is KRW 25,100
+400 (1.62%)
At close: Aug 20, 2026
Curocell Market Cap
Curocell has a market cap or net worth of 382.2 billion as of August 20, 2026. Its market cap has decreased by -23.84% in one year.
Market Cap
382.20B
Enterprise Value
414.19B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
25,100.00
ChartMarket Cap Chart
Since November 9, 2023, Curocell's market cap has increased from 295.40B to 382.20B, an increase of 29.39%. That is a compound annual growth rate of 9.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 382.20B | -41.09% |
| Dec 30, 2025 | 648.75B | 47.92% |
| Dec 30, 2024 | 438.58B | -10.00% |
| Dec 28, 2023 | 487.34B | 64.98% |
| Nov 9, 2023 | 295.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AprilBio | 724.87B |
| ROKIT Healthcare | 522.67B |
| Inventage Lab | 404.96B |
| IntoCell | 314.71B |
| HansBiomed | 293.07B |
| IMBiologics | 256.11B |
| Kangstem Biotech | 242.66B |
| S.Biomedics | 238.91B |